Department of Otorhinolaryngology Head and Neck Surgery, Rabin Medical Center, Petah Tikva, Israel and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Family Medicine, Clalit Health Services, Central District, Tel Aviv, Israel.
Laryngoscope. 2020 Feb;130(2):328-331. doi: 10.1002/lary.27928. Epub 2019 Mar 25.
There is uncertainty regarding the effectiveness of tonsillectomy for recurrent tonsillitis in the adult population. Several studies have described a reduced number and severity of tonsillitis episodes; however, the impact of tonsillectomy on healthcare burden has yet to be studied. The aim of the present study was to evaluate the long-term outcomes of tonsillectomy in the adult population.
A retrospective review of the central database of Clalit Health Services, Tel Aviv, Israel, between 2003 and 2009 was performed. The study included all adult patients (>18 years) who underwent tonsillectomy due to recurrent tonsillitis. Clinical and epidemiological data from 3 years before and after surgery were collected and analyzed.
A total of 3,701 patients were included in the study. Mean age was 37.4 years, and 42.9% were males. Following surgery, there was a significant decrease in the total number of tonsillitis episodes, otolaryngologist clinic visits, consumption of pertinent antibiotics, and respiratory complaints. Moreover, a reduced number of hospitalizations to the otolaryngology department and shorter hospitalization duration were also noted. Although the total number of hospitalizations was unaffected, there was an increase in the number of primary care office visits. Finally, a break-even time analysis revealed an average of 2.7 years following tonsillectomy.
Tonsillectomy for recurrent tonsillitis is effective in decreasing the number and severity of tonsillitis episodes and might also have an economic benefit. The impact of tonsillectomy on general health needs to be further evaluated; however, it appears that there is no increase in overall morbidity.
NA Laryngoscope, 130:328-331, 2020.
成人复发性扁桃体炎行扁桃体切除术的疗效尚不确定。一些研究已经描述了扁桃体炎发作次数和严重程度的减少；然而，扁桃体切除术对医疗保健负担的影响尚未得到研究。本研究旨在评估成人扁桃体切除术的长期疗效。
对以色列特拉维夫的 Clalit 医疗服务中心的中央数据库进行了回顾性研究，研究时间为 2003 年至 2009 年。研究纳入了所有因复发性扁桃体炎而行扁桃体切除术的成年患者（>18 岁）。收集并分析了手术前 3 年和手术后 3 年的临床和流行病学数据。
共有 3701 例患者纳入本研究。患者平均年龄为 37.4 岁，42.9%为男性。手术后，扁桃体炎发作次数、耳鼻喉科就诊次数、相关抗生素的使用和呼吸道症状均显著减少。此外，耳鼻喉科住院次数减少，住院时间缩短。尽管总住院人数没有变化，但初级保健门诊就诊次数增加。最后，平衡时间分析显示，扁桃体切除术后平均 2.7 年达到平衡。
复发性扁桃体炎行扁桃体切除术可有效减少扁桃体炎发作的次数和严重程度，可能具有经济效益。扁桃体切除术对整体健康的影响需要进一步评估；然而，似乎并没有增加整体发病率。
无
